清晰醫療(01406.HK)擴充旺角醫務中心 於尖沙咀開設新中心
清晰醫療(01406.HK)公布,將擴充旺角現有醫療中心,並於尖沙咀設立一間新醫療中心,以提供私營眼科醫療服務。
集團指,近期簽訂一份為期三年的租賃協議,擬通過內部資金擴充集團位於旺角惠豐中心的現有醫務中心。擴充後,新旺角中心的總樓面面積達約5,966平方呎,將主要專注於提供屈光治療服務及其他治療服務,預計新中心將於今年底開始營運。
集團亦簽訂了另一份為期三年的租賃協議,擬計劃使用公司首次公開發售所得款項,於尖沙咀成立新的醫務中心,以提供全面的眼科諮詢、檢查服務及治療服務。新尖沙咀中心將位於「The ONE」商場,總樓面面積達約1.37萬平方呎,預期將於明年第一或第二季前後開始營運。(ek/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.